The cost of intravenous (IV) ceftriaxone can vary depending on several factors, including the dosage, formulation, and the healthcare setting in which it is administered. Generic versions of ceftriaxone are widely available, which generally contributes to lower costs compared to branded drugs.
How Much Does Ceftriaxone IV Typically Cost?
The price for a single dose of IV ceftriaxone can range from approximately $10 to $30 for generic formulations. However, this is a general estimate, and actual costs can be higher. For instance, in hospital settings, the price may be bundled into the overall cost of patient care, making it difficult to isolate the exact cost of the medication itself. Factors such as whether the drug is purchased in bulk by a hospital or acquired on a per-unit basis by a smaller clinic also influence pricing.
What Influences the Price of IV Ceftriaxone?
The cost of IV ceftriaxone is primarily influenced by the manufacturer, as different companies may price their generic products differently. The specific formulation, such as whether it requires reconstitution or is a pre-mixed solution, can also affect the price. Additionally, geographic location and the specific pharmacy or healthcare provider supplying the medication play a role in the final cost.
When Does Ceftriaxone Patent Exclusivity End?
Ceftriaxone is a long-established antibiotic. Its original patents have expired, allowing for the widespread production and sale of generic versions. Information regarding patent expiry dates for specific ceftriaxone formulations or related intellectual property can be found through resources that track drug patents and market exclusivity [1].
Who Manufactures Generic Ceftriaxone IV?
Numerous pharmaceutical companies manufacture generic ceftriaxone for intravenous use. These manufacturers include large generic drug producers as well as smaller regional companies. The availability of multiple generic options generally helps to keep prices competitive.
How Does Ceftriaxone IV Compare to Other IV Antibiotics?
Ceftriaxone is a broad-spectrum cephalosporin antibiotic commonly used to treat a variety of bacterial infections, including pneumonia, meningitis, gonorrhea, and skin infections. Its cost is often considered relatively affordable when compared to some newer, more specialized IV antibiotics, particularly those that are still under patent protection or have limited generic availability. The choice of antibiotic is based on the specific infection, suspected or confirmed pathogens, and local resistance patterns, rather than solely on cost.
Where Can I Find More Information on Drug Pricing and Patents?
For detailed information on drug patent expirations and market exclusivity for ceftriaxone and other medications, resources such as DrugPatentWatch.com can provide comprehensive data [1].
*
**Sources
1. DrugPatentWatch.com. (n.d.). Retrieved from https://drugpatentwatch.com/